Correlation Between Volitionrx and ProPhase Labs
Can any of the company-specific risk be diversified away by investing in both Volitionrx and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Volitionrx and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Volitionrx and ProPhase Labs, you can compare the effects of market volatilities on Volitionrx and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Volitionrx with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Volitionrx and ProPhase Labs.
Diversification Opportunities for Volitionrx and ProPhase Labs
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Volitionrx and ProPhase is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Volitionrx and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Volitionrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Volitionrx are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Volitionrx i.e., Volitionrx and ProPhase Labs go up and down completely randomly.
Pair Corralation between Volitionrx and ProPhase Labs
Given the investment horizon of 90 days Volitionrx is expected to under-perform the ProPhase Labs. In addition to that, Volitionrx is 2.1 times more volatile than ProPhase Labs. It trades about -0.11 of its total potential returns per unit of risk. ProPhase Labs is currently generating about -0.15 per unit of volatility. If you would invest 77.00 in ProPhase Labs on September 14, 2024 and sell it today you would lose (9.00) from holding ProPhase Labs or give up 11.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Volitionrx vs. ProPhase Labs
Performance |
| Timeline |
| Volitionrx |
| ProPhase Labs |
Volitionrx and ProPhase Labs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Volitionrx and ProPhase Labs
The main advantage of trading using opposite Volitionrx and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Volitionrx position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.| Volitionrx vs. Electrocore LLC | Volitionrx vs. Evogene | Volitionrx vs. Evolus Inc | Volitionrx vs. OncoCyte Corp |
| ProPhase Labs vs. Emergent Biosolutions | ProPhase Labs vs. Bausch Health Companies | ProPhase Labs vs. Neurocrine Biosciences | ProPhase Labs vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |